Current Perspective on the Potential Benefits of Smart Insulin Pens on Glycemic Control in Patients With Diabetes: Spanish Delphi Consensus. J Diabetes Sci Technol. 2025 Jan;19(1):123-135. doi: 10.1177/19322968231178022. Epub 2023 Jun 1. PMID: 37264627; PMCID: PMC11688688.F.I.: 3,46 Q1
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study). Eur J Intern Med. 2025 Jan;131:58-64. doi: 10.1016/j.ejim.2024.08.027. Epub 2024 Sep 10. PMID: 39261181. F.I.: 4,49 Q1
Benefits of a comprehensive care model in patients with heart failure and chronic obstructive pulmonary disease: UMIPIC Program. Rev Clin Esp (Barc). 2025 Jan;225(1):1-8. doi: 10.1016/j.rceng.2024.10.006. Epub 2024 Oct 28. PMID: 39490525. F.I.: 1,3 Q3
Biomarkers of oxidation, inflammation and intestinal permeability in persons with diabetes mellitus with parenteral nutrition: A multicenter randomized trial. Clin Nutr. 2025 Jan;44:155-164. doi: 10.1016/j.clnu.2024.11.044. Epub 2024 Dec 3. PMID: 39672082. F.I.: 7,32 Q1
Hemodynamic Management guided by the Hypotension Prediction Index in Abdominal Surgery: A Multicenter Randomized Clinical Trial. Anesthesiology. 2025 Jan 2. doi: 10.1097/ALN.0000000000005355. Epub ahead of print. PMID: 39746186. F.I.: 7,89 Q1
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study. Cancer. 2025 Jan 1;131(1):e35696. doi: 10.1002/cncr.35696. PMID: 39748608. F.I.:6,86 Q1
Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry. Arthritis Res Ther. 2025 Jan 8;27(1):5. doi: 10.1186/s13075-024-03471-x. PMID: 39780297; PMCID: PMC11707992. F.I.: 5,16 Q2
Changes in serum periostin levels in uncontrolled asthma in children (DADO phase 2 study). Allergol Immunopathol (Madr). 2025 Jan 1;53(1):1-7. doi: 10.15586/aei.v53i1.1134. PMID: 39786869.
Some thoughts about the «Consensus statement on smoking and vascular risk» from the Spanish Autonomous Societies of Hypertension and Vascular Risk. Nefrologia (Engl Ed). 2025 Jan;45(1):1-4. doi: 10.1016/j.nefroe.2024.12.002. Epub 2025 Jan 10. PMID: 39799082.
Correlation between metabolic response determined with [18F]FDG PET/CT and pathological response after neoadjuvant treatment and surgery in patients with esophageal cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Jan 23:500088. doi: 10.1016/j.remnie.2025.500088. Epub ahead of print. PMID: 39855559.